How to improve your antibody drug development assays with anti-idiotypic antibodies
These highly specialized antibodies can be used to set up pharmacokinetic (PK) assays in different formats to measure free or total drug levels in preclinical and clinical samples, or as positive controls in anti-drug antibody (ADA) assays.
Listen to our recorded webinar to find out how recombinant monoclonal anti-idiotypic antibodies are generated at Bio-Rad, and how they can be used to develop highly specific and sensitive PK and ADA assays.
The presentation covers how we use HuCAL® technology to overcome the limitations of traditional antibody generation methods, resulting in the fast development of fully human Fab and full immunoglobulin anti-idiotypic antibodies.
Data is presented to show development of antibodies binding specifically and with high affinity to well-known drugs, such as adalimumab, trastuzumab and cetuximab, plus we explain our unique capability for developing antibodies against drug-target complexes.
Speaker: Dr Christian Frisch, R&D Manager, Bio-Rad.
Toll Free: +1 800 265 7376
Tel: +1 919 878 7978
Tel: +49 89 80 90 95 21
Tel: +44 1865 852 700
To discuss a custom HuCAL antibody generation project, contact
Tel: +49 89 80 90 95 45
Or complete our online inquiry form
HuCAL® is a registered trademark of MorphoSys AG.
Payment methods we support: